Skip to content

A multicenter, retrospective longitudinal observational study about Quarantine and social Isolation for COVID-19 and its impact on Kawasaki disease

A multicenter, retrospective longitudinal observational study about Quarantine and social Isolation for COVID-19 and its impact on Kawasaki disease - QUICK study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000041579
Enrollment
5000
Registered
2020-08-28
Start date
2020-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kawasaki disease

Interventions

None listed

Sponsors

Fukuoka Children's Hospital Kawasaki disease center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) patient admitted from 2017 to 2020. 2) patient admitted with a diagnosis of KD or an infectious disease. The diagnosis of KD was made based on Japanese diagnostic guidelines for Kawasaki disease. Both complete and incomplete KD are included. Include infectious diseases are as follows; respiratory tract infection (respiratory syncytial virus (RSV), human metapneumovirus (hMPV), adenovirus, influenza virus, Streptococcus pyogenes, the others, and unknown pathogens), gastrointestinal infection, exanthema subitum, skin and soft tissue infection. In patients with respiratory tract infections, pathogens are identified with serological tests, culture, or rapid immunochromatographic tests.

Exclusion criteria

Exclusion criteria: 1) admission for the recurrence of the same disease within 4 weeks 2) patient with immunodeficiency 3) patient with rheumatic disease, autoimmune disease or malignant disease 4) patient receiving immunosuppressive agents 5) patient who moved from other medical areas within 2 weeks before admission.

Design outcomes

Primary

MeasureTime frame
The ratio of the number of patients with KD to patients with infections was admitted from February to May 2015-2019 and 2020.

Secondary

MeasureTime frame
Clinical features of Kawasaki Disease in 2020.

Countries

Japan

Contacts

Public ContactKenji Furuno

Fukuoka Children's Hospital Kawasaki disease center

furuno.k@kd-research.com+81-92-682-7000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026